» Articles » PMID: 37370770

Clinical Features and Management of Acute and Chronic Radiation-Induced Colitis and Proctopathy

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2023 Jun 28
PMID 37370770
Authors
Affiliations
Soon will be listed here.
Abstract

Background: RICAP is a recognized adverse effect of radiation therapy (RT) that can adversely affect cancer patients' quality of life. Data on the clinical characteristics and outcomes of RICAP are scarce. We aimed to analyze the clinical and endoscopic characteristics of acute or chronic radiation-induced colitis and proctopathy (ARICAP and CRICAP) based on symptom onset after RT (≤ or >45 days, respectively).

Methods: This is a retrospective observational study of a single tertiary cancer center, from January 2010 and December 2018, of cancer patients with endoscopically confirmed ARICAP and CRICAP. We conducted univariate and multivariate logistic regression analyses to associate clinical variables with endoscopic and medical outcomes.

Results: One hundred and twelve patients were included (84% Caucasian; 55% female; median age of 59 years); 46% had ARICAP with non-bloody diarrhea as the predominant symptom, whereas 55% had CRICAP with mostly bloody diarrhea. Neovascularization was the most frequent finding on endoscopy, followed by bleeding. ARICAP patients more often received medical management ( < 0.001), whereas CRICAP patients with bleeding more often received argon plasma coagulation (APC) ( = 0.002). Female sex and undergoing less-intense RT treatments were more associated with medical treatment; bleeding clinically and during the endoscopy was more associated with APC treatment. However, APC treatment did not significantly reduce bleeding recurrence or RICAP symptoms.

Conclusion: Patients with ARICAP and CRICAP experience different symptoms. Medical management should be considered before endoscopic therapy. APC may be useful in patients with endoscopically apparent bleeding.

References
1.
Coia L, Myerson R, Tepper J . Late effects of radiation therapy on the gastrointestinal tract. Int J Radiat Oncol Biol Phys. 1995; 31(5):1213-36. DOI: 10.1016/0360-3016(94)00419-L. View

2.
Abu-Sbeih H, Ali F, Luo W, Qiao W, Raju G, Wang Y . Importance of endoscopic and histological evaluation in the management of immune checkpoint inhibitor-induced colitis. J Immunother Cancer. 2018; 6(1):95. PMC: 6156850. DOI: 10.1186/s40425-018-0411-1. View

3.
Lee J, Agrawal D, Thosani N, Al-Haddad M, Buxbaum J, Calderwood A . ASGE guideline on the role of endoscopy for bleeding from chronic radiation proctopathy. Gastrointest Endosc. 2019; 90(2):171-182.e1. DOI: 10.1016/j.gie.2019.04.234. View

4.
Waye J . Comment on: Fujii T, Hasegawa RT, Sitoh Y et al. Chromoscopy during colonoscopy. Endoscopy 2001; 33:1036-1041. Endoscopy. 2002; 34(1):92. View

5.
Weiner J, Wong A, Schwartz D, Martinez M, Aytaman A, Schreiber D . Endoscopic and non-endoscopic approaches for the management of radiation-induced rectal bleeding. World J Gastroenterol. 2016; 22(31):6972-86. PMC: 4988305. DOI: 10.3748/wjg.v22.i31.6972. View